|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for weight... |
|
|
P/S
|
Promoting public awareness for weight reduction and long term weight loss maintenance. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes;
pharmaceutical preparations for weigh... |
|
|
Invention
|
Homing endonuclease variants.
The present disclosure provides homing endonuclease variants and m... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes and obesity, pharmaceutical preparation... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes
and obesity, pharmaceutical preparatio... |
|
|
Invention
|
Anti il-6 domain antibodies with fatty acid substituents.
The present invention relates to compo... |
|
|
Invention
|
Method and equipment for fractionation of granules for use in pharmaceutical compositions.
A sie... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes |
|
|
Invention
|
Production of cryonoids and blood cells derived therefrom.. The present invention relates to the ... |
|
|
Invention
|
Stat3 targeting oligonucleotides and uses thereof.
The subject matter disclosed herein is direct... |
|
|
Invention
|
Oral dosing of glp-1 compounds.
The present invention relates to improved uses of GLP-1 peptides... |
|
|
P/S
|
Custom manufacturing of medical products. |
|
|
Invention
|
Pcsk9 endonuclease variants, compositions, and methods of use.
The present disclosure provides i... |
|
|
Invention
|
Semaglutide in medical therapy.
The present invention relates to semaglutide for use in weight m... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
|
P/S
|
Pharmaceutical preparations for weight reduction and long-term weight loss maintenance. |
|
|
Invention
|
Injection device for delivering a plurality of pre-defined fixed doses. The invention relates to ... |
|
|
Invention
|
Syringe device with a dose limiting mechanism and an additional safety mechanism.
A syringe devi... |
|
|
Invention
|
Compositions of glp-1 peptides and preparation thereof.
The invention relates to pharmaceutical ... |
|
|
P/S
|
Custom manufacturing of chemicals, biochemical, and pharmaceuticals. |
|
|
Invention
|
Treatment and prevention of cardiac and fibrotic disorders. The invention relates to an oligonucl... |
|
|
Invention
|
Protracted ccr5 antagonists and uses thereof. A CCR5 antagonist comprising a polypeptide comprisi... |
|
|
Invention
|
Stabilised protein solutions.
The invention relates to a method of stabilizing highly concentrat... |
|
|
Invention
|
Injection device with suspended front. The present invention provides a drug delivery device (1, ... |
|
|
P/S
|
Recorded computer software for predicting medical treatment effects.. Promotion via a website, of... |
|
|
Invention
|
Pharmaceutical formulations.
Disclosed herein are an aqueous pharmaceutical formulation comprisi... |
|
|
Invention
|
Semaglutide in cardiovascular conditions.
The present invention relates to the GLP-1 receptor ag... |
|
|
Invention
|
Adeno-associated virus vector sequence. The invention relates to adeno-associated virus (AAV) vec... |
|
|
Invention
|
Albumin-targeted endonucleases, compositions, and methods of use. e.ge.g., by enabling insertion ... |
|
|
Invention
|
Semaglutide for use in medicine.
The present invention is directed to use of the GLP-1 receptor ... |
|
|
P/S
|
Electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medica... |
|
|
P/S
|
Downloadable software in the nature of mobile applications for the treatment of medical condition... |
|
2024
|
Invention
|
Fermentation process. The invention fermentation processes for recombinantly producing a target p... |
|
|
Invention
|
A method for cci testing. The present invention provides a method of testing container closure in... |
|
|
Invention
|
System and methods for counter-current filtration. The invention relates to systems and methods f... |
|
|
Invention
|
Human cd30 ligand antigen binding proteins.
Provided are compositions and methods relating to hu... |
|
|
Invention
|
Stable liquid formulations. The application relates to the development of an improved antibody fo... |
|
|
Invention
|
Tri-agonists of the glp-1, gip, and amylin receptors. The present invention relates to a GLP-1-/G... |
|
|
Invention
|
Injection device with machine-readable coding. The present invention provides an injection device... |
|
|
Invention
|
Drug delivery device with drive spring. A drug delivery device comprising a housing in which a sp... |
|
|
Invention
|
Drug delivery device with safety release member. A drug delivery device comprising a needle unit ... |
|
|
Invention
|
Adaptive cartridge holder for drug delivery device. A cartridge holder adapted to receive a cylin... |
|
|
Invention
|
Fixed dose drug delivery device with rotational controller. A drug delivery device comprising a s... |
|
|
Invention
|
Shielded needle unit with lock indicator. A needle unit adapted to be mounted on a drug delivery ... |
|
|
Invention
|
Method and arrangement for non-destructive cci testing. The present invention provides a method o... |
|
|
Invention
|
Methods for preventing unwanted cells arising during differentiation of human pluripotent stem ce... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease,... |
|
|
Invention
|
Drug delivery device.
A drug delivery device for administration to a subject is provided. In som... |
|
|
Invention
|
P-selectin peptide ligands. The present invention relates to peptide ligands of P-selectin compri... |
|
2023
|
Invention
|
Purine compounds, compositions comprising them and uses thereof.
The present document ... |
|
|
Invention
|
Prodrugs of glp-1 polypeptide and uses thereof.
The invention relates to DKP-based prodrugs from... |
|
|
Invention
|
Methods for synthesis of peracetylgalactosamine-1-pentanoic acid.
The disclosure provides method... |
|
|
Invention
|
Dose logging device with scale drum scanner.
A drug delivery device comprising a housing with an... |
|
|
Invention
|
Decarboxylative acetoxylation using mn(ii) or mn(iii) reagent for synthesis of 4'-acetoxy-nucleos... |
|
|
Invention
|
Dose logging assembly with rotational transmission feature.
Add-on device comprising a housing, ... |
|
|
Invention
|
Methods for treating subjects with abdominal obesity hypertriglyceridemia and/or impaired glucose... |
|
|
Invention
|
Crystalline forms of n-{[(s)-{[3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1h-pyrazol-1-yl][4-(triflu... |
|
|
Invention
|
Pyrazolopyrimidines, compositions comprising them and uses thereof.
The present document relates... |
|
2022
|
Invention
|
Process for the backbone deprotection of oligonucleotides containing a terminal alkyl phosphonate... |
|
|
Invention
|
Injection device |
|
2021
|
Invention
|
Glp-1 prodrugs and uses thereof.
The invention relates to DKP-based prodrugs. The invention also... |
